New SCOPE module on chronic kidney disease and obesity | World Obesity Federation

New SCOPE module on chronic kidney disease and obesity

NewsNew SCOPE module on chronic kidney disease and obesity

Renowned author and expert in the field of nephrology, Matthew R. Weir, MD, has authored a new module on the complex relationship between obesity and chronic kidney disease.

This comprehensive course offers an in-depth understanding of the potential pathophysiologic processes that can increase the risk for chronic kidney disease progression, and the management plans that can slow its progression.

The course covers the association between obesity and chronic kidney disease, including the risk for incident chronic kidney disease and the progression of the disease. The module also highlights the importance of recognising that even metabolically healthy obesity is associated with increased risk for chronic kidney disease.

The module offers healthcare professionals a detailed understanding of the many potential pathophysiologic processes that can increase the risk for chronic kidney disease progression. With incremental understanding about the pathophysiology of obesity-related chronic kidney disease, newer therapeutic strategies may provide an important opportunity to slow the progression of the disease.

With this essential resource, healthcare professionals will gain an invaluable insight into managing patients with obesity and chronic kidney disease. The course includes effective management plans, including behavioural, pharmacological, and surgical approaches to slow the progression of the disease. The module is essential for all health professionals treating patients with obesity and chronic kidney disease.
 

Ready to get started with SCOPE?

Register for SCOPE E-Learning to discover dozens of free, CME accredited modules.
One quick form, no commitment required. Available in Portuguese, Spanish and French.

GO TO SCOPE E-LEARNING

Related News

View all

News SCOPE Mar 30, 22

New SCOPE module on pharmacotherapy for obesity

Significant advancements have been made in the field of obesity pharmacotherapy recent years, now reflected in SCOPE.

Read Post

News SCOPE Feb 28, 23

SCOPE hosts World Obesity Day webinar on child obesity

This webinar explored the growing issue of childhood obesity, a serious global public health challenge.

Read Post

News SCOPE Feb 22, 23

New SCOPE module on NAFLD/NASH and obesity is now available

SCOPE has released a new two-part module on obesity and non-alcoholic fatty liver disease (NAFLD).

Read Post